The FUNNY trial is an international, phase IIa, triple blind, placebo controlled randomised trial, targeting heart rate control using the funny current inhibitor ivabradine, to reduce morbidity in patients undergoing non-cardiac surgery.
The trial is expected to launch in 2020 and will take place in the UK and Switzerland. Patients will be enrolled over a three-year recruitment window across all hospitals.
As the trial progresses, the website will be regularly updated with the latest news and documents for you to freely access. For any trial related queries, please directly contact the trial management team.